Skip to main content
From L to R: Thomas Hannich, Anna Koren, Prudence Donovan, Stefan Kubicek, André Müller and Christoph Bock (© Laura Alvarez / CeMM).

Meet CeMM at BIO-Europe Digital on 25-28 October 2021

As a pioneering institute with the goal of achieving maximum scientific innovation in molecular medicine to improve healthcare, CeMM is fully committed to identifying, supporting, and developing its research discoveries into impactful solutions for society. In line with this, once again this year on 25-28 October, CeMM will be joining the BIO-Europe Digital conference, the meeting point for global biopharma and investment leaders to build partnerships that facilitate innovation and medical breakthroughs. 

CeMM IP and Technology Transfer Manager, Prudence Donovan, together with the heads of CeMM services and facilities, Christoph Bock,…

Read more
Colored microscopy image of the monolith, © Lahnsteiner M, Unterlass M, published in the Royal Society of Chemistry's peer-reviewed Journal of Materials Chemistry A, 2021.

Eco-friendly process for synthesizing organic materials developed for high-performance materials industry

Until now, the production of materials from organic substances was only possible with the use of highly toxic solvents. A team led by chemist Miriam Unterlass, Professor at the University of Konstanz and Adjunct Principal Investigator at CeMM, has now developed a method for making organic substances suitable for use as high-performance materials in an eco-friendly and completely non-toxic way by generating them in only hot water. The study represents an important milestone in the green production of organic materials and thus also provides an important incentive to switch from inorganic to organic, renewable materials. Beside that the method…

Read more
RESOLUTE Scientific Project Manager Tabea Wiedmer, Schoolteacher Alexandra Schmidl and RESOLUTE Senior Scientist Gernot Wolf / Laura Alvarez, CeMM

Seitenwechsel candidate Alexandra Schmidl joins CeMM for a year

On 6 September 2021, schoolteacher Alexandra Schmidl joins CeMM as part of the Seitenwechsel program, which fosters fruitful exchanges among companies and teachers in Austria. During the next year, she will have a full immersion in the scientific environment at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, where she will benefit from daily interactions with CeMM researchers. The knowledge and new techniques that she acquires, will be then applied in her teaching when she goes back to her classroom next year. CeMM will not only profit from her everyday school life know-how, but will also gain further…

Read more
Kaan Boztug, St. Anna Children's Cancer Research (Photographer: Ian Ehm).

Kaan Boztug receives the "Işil Berat Barlan Award for Primary Immunodeficiency Diseases"

Congratulations to Kaan Boztug, Scientific Director of the St. Anna Children's Cancer Research Institute, Director of the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases and CeMM Adjunct Principal Investigator, who has been awarded the Işil Berat Barlan Award for his outstanding research in the field of primary immunodeficiencies, which will be presented for the first time this year at the European Congress of Immunology (ECI).

The scientist receives this award for his pioneering research on immunodeficiencies. Disturbances in the balance of the immune system can be the starting point for a number of diseases such as increased…

Read more
Robert Kralovics (© Belle & Sass / CeMM).

CeMM bids farewell to Robert Kralovics

Robert Kralovics has been associated with CeMM for 15 years, being one of the very first internationally recruited Principal Investigators to join our institute. On 31 August 2021, his CeMM affiliation comes to an end, and therefore we would like to thank him greatly for all his scientific contributions and personal engagement with CeMM and our community.

Robert earned his master’s degree in Molecular Biology and Genetics at Comenius University and his PhD in Genomics at the Institute of Biophysics of the Academy of Sciences of the Czech Republic. His postdoctoral work was based on the genetics of myeloproliferative disorders working with…

Read more
CeMM team: IP & Technology Transfer Manager Prudence Donovan, Administrative Director Anita Ender, Scientific Director Giulio Superti-Furga; © Michael Sazel, CeMM.

CeMM receives “Innovation Award 2021/2022” for Inorganic Chemistry and is one of the most innovative companies in Vienna

For the second time, CeMM wins the Innovation Award of the ÖGVS – Gesellschaft für Verbraucherstudien (Society for Consumer Studies). Measured by the number of patents granted worldwide and supplemented by the qualitative moment of citation frequency, CeMM ranks in the top group of the main class Inorganic Chemistry as well as in the top 10% of the most innovative companies and research institutions in Vienna.

At CeMM internationally recognized cutting-edge research is conducted in the field of molecular medicine. CeMM integrates basic research and clinical expertise to develop innovative diagnostic and therapeutic approaches to improve…

Read more

Minister Wolfgang Mückstein visited CeMM

On July 30, 2021, CeMM was honored to welcome Dr. Wolfgang Mückstein, Austrian Federal Minister of Social Affairs, Health, Care and Consumer Protection. This was the first visit of Minister Mückstein to our institute, and we are very grateful for this opportunity to present CeMM, our research highlights and innovations. CeMM actively supported the AGES and the Ministry in fighting the pandemic, by analyzing and integrating Austrian viral genome data into a global map of SARS-CoV-2 mutations, which helped decipher the mutational dynamics underlying the COVID-19 pandemic.

Minister Mückstein was welcomed by CeMM Directors Giulio Superti-Furga…

Read more
CeMM Adjunct PI Joanna Loizou (© Klaus Pichler / CeMM).

Joanna Loizou awarded the prestigious Mannagetta Prize of the Austrian Academy of Sciences

CeMM congratulates Adjunct Principal Investigator Joanna Loizou on being awarded the Mannagetta Prize of the Austrian Academy of Sciences for her remarkable research work in the field of genome stability in oncology. In 2021, the Johann Wilhelm Ritter von Mannagetta Award for Medicine is given for outstanding work investigating the mechanisms of cancer genesis.

Understanding complex systems to pave the way for better cancer treatment is the goal of molecular biologist Joanna Loizou. Cancer develops when DNA damage blocks the human cell's conventional control mechanisms. But what genetic interactions are required for DNA repair and cell…

Read more
CeMM Administrative Director Anita Ender, CeMM HR Expert Memo Mokhles and Aids-Hilfe Wien Managing Director Andrea Brunner (©Aids Hilfen Österreichs/Jürgen Hammerschmid).

CeMM signs the #positivarbeiten declaration to promote inclusion towards HIV-positive employees

Diversity, professionalism, and respect are core values at CeMM, we actively promote respectful cooperation in an open and inclusive workplace. On 28 June 2021, the signing of the #postivearbeiten declaration took place at CeMM, symbolizing yet another step forward in our continuous commitment to provide all our employees with an optimal work environment where they can develop themselves and contribute to CeMM’s success in the field of medical research.

With timely diagnosis and treatment, people with HIV have nowadays an almost average life expectancy and can live and work like other people. For many HIV-positive people, discrimination and…

Read more
New Principal Investigator Clarissa Campbell (© Natascha Unkart belle&sass / CeMM).

New CeMM Principal Investigator Clarissa Campbell

On 1 July 2021, Clarissa Campbell joins CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, as new Principal Investigator. She focuses on intestinal pathogens and intestinal immune homeostasis, thus strengthening CeMM’s core expertise in the fields of immunity and metabolism.

Clarissa Campbell studied biology with a minor in genetics at the Federal University of Rio de Janeiro (UFRJ), and subsequently earned a master’s degree from the Oswaldo Cruz Foundation (FIOCRUZ) investigating how bacterial molecules exert immunomodulatory effects on mammalian cells via nuclear receptors, a topic she would continue to…

Read more